Ask Mallard

Case-control study

A case-control study starts with people who have an outcome and a comparable group who do not, then compares their prior exposures.
NHMRC EVIDENCE LEVEL · 2009Depends on the research questionProvisional design classification. Study quality and certainty of findings require separate appraisal.
Why this level?Specify the research question: intervention, diagnostic accuracy, prognosis, aetiology, or screening intervention. Other question types are outside this hierarchy. NHMRC 2009 source

Intervention case-control studies with concurrent controls and aetiology case-control studies occupy different categories. For aetiology the same sampling family has a different level. Selection of controls and the timing of exposure ascertainment still need careful appraisal.

Where the NHMRC 2009 hierarchy names this design, it places it here:

Research questionLevelWhen
InterventionIII-2An observational comparison uses concurrent controls. Statistical adjustment does not change this design level.
AetiologyIII-3A case-control study examines the exposure in people selected by outcome status.

What question does this help answer?

“Were people with this outcome more likely than appropriate controls to have had a particular prior exposure?”

When to use it

Case-control designs are especially useful for rare outcomes, long-latency diseases, or questions where assembling a full cohort would be inefficient.

When not to use it

It is usually a poor choice when the exposure itself is rare, when valid controls cannot be drawn from the same source population as the cases, or when exposure information is highly vulnerable to differential recall or recording.

How it works in plain language

Cases are selected because they have the outcome. Controls should represent the exposure distribution that would have been observed in the population that produced the cases. Researchers then compare previous exposure between cases and controls, usually estimating an odds ratio.

What the sampling looks like

A case-control study drawn as sampling from one source population followed over time. People who develop the outcome become cases; controls are sampled from the same population; exposure is looked up for both in a window before each case's index date.One source population, followed over time. Cases and controls are both drawn from itExposure looked upExposure looked upCaseControlNot sampledCaseControlNot sampledTimeControls stand for the exposure pattern of the population that produced the cases. Time still runsforward: exposure is looked up in the period before each case's index date.Becomes a case (index date)Sampled as a control on that date
Conceptual diagram. It shows the structure of the idea, not data from any study.

What a Table 1 looks like, by case status

Table 1. Baseline characteristics, by group
Illustrative placeholder. Every value in this table is invented to show the shape of the result, and is not an estimate of anything.
CharacteristicGroup 1 (n = 250)Group 2 (n = 250)P value
Age, mean (SD), y64.2 (12.1)63.0 (13.1).07
Female, No. (%)142 (56.8)138 (55.2).74
Comorbidity index, mean (SD)2.6 (1.7)2.5 (1.9).54
Insurance type, No. (%)62 (27.2)56 (25.2).64
Baseline severity score, mean (SD)5.4 (2.2)5.2 (2.4).75
Continuous variables as mean (SD), categorical as No. (%) with denominators, exact P values (AMA/JAMA style). The study site and the calendar period are absent on purpose: a model conditions on them, but they are not characteristics of a participant. The comorbidity index is continuous even though it sounds categorical, so it belongs in the mean (SD) rows.

Why Mallard may recommend it

Mallard may recommend a case-control design when the outcome is uncommon and the user has a defensible source population and reliable historical exposure data.

Key assumptions and design requirements

  • Cases and controls come from the same underlying source population.
  • Control selection is independent of exposure except through appropriate sampling.
  • Exposure is measured comparably in cases and controls.
  • Confounders are identified using design and subject-matter knowledge.
  • Matching, if used, is reflected correctly in analysis.

What to watch out for

Poor control selection can invalidate the study. Recall bias, selection bias, overmatching, and interpreting an odds ratio as if it were always a risk ratio are common problems.

Clinical example

Identify patients with a rare postoperative complication and controls from patients who underwent the same procedure without the complication, then compare prior exposure to a medication.

Recent studies that used this
Searching PubMed…
Related Learn pages
Sources & further reading
  1. STROBE statement for observational studies (opens in a new tab) · EQUATOR Network
  2. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies (opens in a new tab) · BMJ · doi 10.1136/bmj.39335.541782.AD
  3. Case-control studies: Increasing scientific rigor in control selection (opens in a new tab) · Res Pract Thromb Haemost · doi 10.1016/j.rpth.2023.100090
  4. Observational studies: cohort and case-control studies (opens in a new tab) · Plast Reconstr Surg · doi 10.1097/PRS.0b013e3181f44abc
STROBE is primarily a reporting guideline, not a design manual. Use it to improve transparency, not as a substitute for careful causal design.
Last source review: 2026-09-05
AI-generated educational content
Mallard uses reputable methodological and reporting sources, but this material may contain errors or omit important context. Verify important methodological decisions with the cited sources and, when appropriate, a qualified research methodologist or statistician.